Vietnam Investment Review on MSN
Texas Institute Implants First Novel Defibrillation Lead
AUSTIN, Texas, Feb. 2, 2026 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an ...
EU recommends approval of AstraZeneca’s Imfinzi perioperative regimen for patients with early gastric and gastroesophageal cancers ...
George H. Crossley, M.D.; Kazutaka Aonuma, M.D.; Charles Haffajee, M.D.; Morio Shoda, M.D.; Albert Meijer, M.D.; Alexander Bauer, M.D.; Alexander Bauer, M.D ...
Recommendation based on MATTERHORN Phase III trial results which showed a 29% reduction in the risk of progression, recurrence or death and a 22% ...
TCAI is a state-of-the-art Electrophysiology Center that includes six labs equipped with advanced technology where a group of ...
February 2026 Imfinzi perioperative regimen recommended for approval in the EU by CHMP for patients with early gastric and gastroesophageal cancers Recommendation based on MATTERHORN Phase III trial ...
Heart failure symptoms have been reversed in patients with a new pacemaker that changes how the heart is fuelled. Scientists ...
At the start of 2026, forward-thinking providers are embracing three innovative products from REJUVA FRESH®, designed to set ...
In the spotlight are the following three breakthrough devices: CaviTONE (TM) LEGACY, FlowWave Focus (TM), and SmartPulse (TM) COOL Professional CO2 Fractional Laser (TM), offering practitioners new ...
SINGAPORE: Art therapy is gaining traction across Singapore’s hospitals as a way to help patients with their mental health, particularly for those coping with chronic illness, trauma and emotional ...
Hi, and welcome to another edition of our CEO Chats. My name is David Bautz, Senior Biotech Analyst with Zacks Small Cap Research . Joining me today is Mr. Eric Schlorff. He's the CEO of SeaStar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results